SOLOIST-WHF is the first large randomised controlled study to demonstrate that the use of SGLT inhibitors for acute HF in stabilised patients is safe and effective.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,